What is Accuray's market cap?

Accuray (ARAY) has a market capitalization of $26.8M and trades on NASDAQ.

Who are Accuray's competitors?

Accuray's key competitors include Sensus Healthcare, Inc, American Shared Hospital Services, PROCEPT BioRobotics Corporation Common Stock, and others. These companies compete in similar markets and product categories.

Who does Accuray partner with?

Accuray's notable partners include RaySearch Laboratories AB, Brainlab, GE Healthcare, and others.

What subsidiaries does Accuray have?

Accuray's subsidiaries include Accuray Asia Limited, CNNC Accuray (TianJin) Medical Technology Co. Ltd..

Where is Accuray headquartered?

Accuray is headquartered in United States of America and employs approximately 1,024 people. It has been publicly traded since 2007.

Accuray

ARAY

Accuray Incorporated is a medical technology company that develops and manufactures advanced radiation therapy solutions for cancer and other disorders.

Market cap

$26.77M-80.6%

Table of contents

Earnings

Q1 2026 report

May 6, 2026

Revenue$104.8MMiss by $7.1M EPS-$0.09Miss by $0.04

Read the full report

Next report

Aug 12, 2026 (In 1 week)

Revenue estimate$105.3M

EPS estimate-$0.03

Competitors

By market cap

Intuitive Surgical$127.84B-27.8%

RadNet$4.8B+8.8%

PROCEPT BioRobotics Corporation$1.0B—

AngioDynamics$564.6M+52.4%

ClearPoint Neuro$437.8M+41.2%

Sensus Healthcare$49.7M-43.2%

Accuray$26.8M-81.3%

AMS

American Shared Hospital Services$10.2M-40.5%

By revenue growth

PROCEPT BioRobotics Corporation+29.3%

ClearPoint Neuro+26.0%

Intuitive Surgical+20.7%

RadNet+14.7%

AngioDynamics+9.5%

By net margin

Intuitive Surgical28.45%-0.1pp

RadNet-0.662%+1.1pp

AngioDynamics-11.48%+0.1pp

PROCEPT BioRobotics Corporation-31.82%+4.4pp

ClearPoint Neuro-71.57%-7.1pp

Profile

Accuray Incorporated is a medical technology company that develops and manufactures advanced radiation therapy solutions for cancer and other disorders. The company provides robotic and helical radiation delivery systems designed to improve treatment accuracy and patient outcomes while minimizing damage to healthy tissue. Its core value proposition centers on high-precision, AI-driven systems that adapt to patient motion in real-time.

Competitive position

Accuray is a specialized leader in robotic and helical radiation therapy, competing against larger diversified medical technology firms by focusing on high-precision motion management and AI-driven adaptive treatments.

GeographiesUnited States, China, Japan, Europe, Canada

Customer segmentsHospitals, Specialized cancer centers, Neurosurgeons, Radiation oncologists

Business modelCapital equipment sales, Service and maintenance contracts, Software licensing

SuppliersRobotic manipulator suppliers, Magnetron and solid-state modulator manufacturers, Treatment couch suppliers, Computer and software component providers

CustomersPublic and private hospitals, Stand-alone oncology clinics, Academic medical centers, Group purchasing organizations (GPOs)

CountryUnited States of America

Listed2007

Employees1.0K

CEOStephen R. LaNeve

SectorHealthcare

IndustryMedical - Specialties

Websiteaccuray.com

FilingsSEC EDGAR

Questions, answered.

What is Accuray's market cap?: Accuray (ARAY) has a market capitalization of $26.8M and trades on NASDAQ.
Who are Accuray's competitors?: Accuray's key competitors include Sensus Healthcare, Inc, American Shared Hospital Services, PROCEPT BioRobotics Corporation Common Stock, and others. These companies compete in similar markets and product categories.
Who does Accuray partner with?: Accuray's notable partners include RaySearch Laboratories AB, Brainlab, GE Healthcare, and others.
What subsidiaries does Accuray have?: Accuray's subsidiaries include Accuray Asia Limited, CNNC Accuray (TianJin) Medical Technology Co. Ltd..
Where is Accuray headquartered?: Accuray is headquartered in United States of America and employs approximately 1,024 people. It has been publicly traded since 2007.